Description
Reg. No. G3867 (Act 36/1947)
Namibia Reg. No. V10/24.4/719 [NS0]
INDICATIONS
Respiravax is an inactivated vaccine for the prophylactic immunisation of calves and pregnant cows as an aid in reducing or preventing bovine respiratory disease caused by Bovine Herpes Virus 1 (IBRV), Bovine Viral Diarrhoea Virus type 1 (BVDV), Parainfluenza Virus type 3 (PI3V) and Mannheimia (Pasteurella) haemolytica.
COMPOSITION
Respiravax is a ready-to-use aqueous vaccine containing inactivated BHV 1 (IBR), PI3 and BVD type 1 viruses, as well as a leukotoxin-containing cell-free supernatant of Mannheimia
haemolytica, adsorbed onto alhydrogel. Viruses are propagated in tissue culture, inactivated with formaldehyde and diluted to 106 TCID50 for IBR and PI3 and 105 TCID50 for BVDV per 1 mℓ dose. The leukotoxin component is a dilution of the cell-free supernatant of a 3-hour fermentation culture. The vaccine contains no preservative, other than formaldehyde.
